Castle Biosciences (CSTL) Q2 2023 Earnings

2AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.1
-0.97
-0.83
-0.7

Details

Expected EPS
-1.01
Actual EPS
-0.7
Surprise EPS
0.31
Surprise Percent
+30.69%

Description

Castle Biosciences (CSTL) has reported earnings of -0.7 per share for Q2 2023.

0 Comments

Share your thoughts